Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis
- PMID: 16691359
- DOI: 10.1007/s11373-006-9088-4
Polypyrimidine-tract-binding protein is a component of the HCV RNA replication complex and necessary for RNA synthesis
Abstract
The machinery for hepatitis C virus (HCV) RNA replication is still poorly characterized. The relationship between HCV RNA replication and translation is also not clear. We have previously shown that a cellular protein polypyrimidine-tract-binding protein (PTB) binds to HCV RNA at several different sites and modulates HCV translation in several ways. Here we show that PTB also participates in RNA replication. By bromouridine triphosphate (BrUTP) labeling and confocal microscopy of cells harboring an HCV replicon, we showed that the newly synthesized HCV RNA was localized to distinct structures in the cytoplasm, which also contain PTB. Membrane flotation analysis demonstrated that a fraction of cytoplasmic PTB was associated with a detergent-resistant membrane (DRM) structure consisting of lipid rafts, which also contained HCV nonstructural proteins and the human vesicle-associated membrane protein-associated protein (hVAP-33). PTB in the DRM was resistant to protease digestion, but became sensitive after treatment with the raft-disrupting agents. PTB in the DRM consisted of multiple isoforms and the brain-specific paralog. By using small interfering RNA (siRNA) of PTB, we showed that silencing of the endogenous PTB reduced the replication of HCV RNA replicon. In a cell-free, de novo HCV RNA synthesis system, HCV RNA synthesis was inhibited by anti-PTB antibody. These studies together indicated that PTB is a part of the HCV RNA replication complex and participates in viral RNA synthesis. Thus, PTB has dual functions in HCV life cycle, including translation and RNA replication.
Similar articles
-
The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA.Virus Res. 2006 Jan;115(1):1-8. doi: 10.1016/j.virusres.2005.06.012. Epub 2005 Aug 15. Virus Res. 2006. PMID: 16102869
-
Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.Virology. 2004 Jul 1;324(2):450-61. doi: 10.1016/j.virol.2004.03.034. Virology. 2004. PMID: 15207630
-
An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence.Virology. 1999 Feb 15;254(2):288-96. doi: 10.1006/viro.1998.9541. Virology. 1999. PMID: 9986795
-
Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein.Biochem Soc Trans. 2008 Aug;36(Pt 4):641-7. doi: 10.1042/BST0360641. Biochem Soc Trans. 2008. PMID: 18631133 Review.
-
[Role of lipid rafts in hepatitis C virus life cycle].Postepy Biochem. 2007;53(4):334-43. Postepy Biochem. 2007. PMID: 19024898 Review. Polish.
Cited by
-
Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.Signal Transduct Target Ther. 2020 Jul 13;5(1):125. doi: 10.1038/s41392-020-00233-4. Signal Transduct Target Ther. 2020. PMID: 32661235 Free PMC article. Review.
-
A cell-permeable peptide inhibits hepatitis C virus replication by sequestering IRES transacting factors.Virology. 2009 Nov 10;394(1):82-90. doi: 10.1016/j.virol.2009.08.012. Epub 2009 Sep 8. Virology. 2009. PMID: 19740508 Free PMC article.
-
SYNCRIP (synaptotagmin-binding, cytoplasmic RNA-interacting protein) is a host factor involved in hepatitis C virus RNA replication.Virology. 2009 Apr 10;386(2):249-56. doi: 10.1016/j.virol.2009.01.018. Epub 2009 Feb 20. Virology. 2009. PMID: 19232660 Free PMC article.
-
Role of Ras-related Nuclear Protein/Polypyrimidine Tract Binding Protein in Facilitating the Replication of Hepatitis C Virus.J Clin Transl Hepatol. 2021 Aug 28;9(4):458-465. doi: 10.14218/JCTH.2020.00122. Epub 2021 Jun 18. J Clin Transl Hepatol. 2021. PMID: 34447674 Free PMC article.
-
PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2.PLoS One. 2011;6(10):e25419. doi: 10.1371/journal.pone.0025419. Epub 2011 Oct 11. PLoS One. 2011. PMID: 22022391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources